Physiomics (LON:PYC) Shares Down 7.4% – Time to Sell?

Physiomics Plc (LON:PYC) shares traded down 7.4% during mid-day trading on Thursday. The stock traded as low as GBX 0.40 and last traded at GBX 0.44. 15,677,377 shares were traded during mid-day trading, an increase of 182% from the average session volume of 5,550,020 shares. The stock had previously closed at GBX 0.47.

Physiomics Trading Down 7.4%

The firm has a market cap of £1.99 million, a PE ratio of -2.93 and a beta of 1.05. The company’s 50-day moving average is GBX 0.50 and its 200 day moving average is GBX 0.49.

Physiomics (LON:PYC) last posted its earnings results on Tuesday, October 13th. The company reported GBX (0.20) EPS for the quarter. Physiomics had a negative return on equity of 152.03% and a negative net margin of 74.06%. On average, research analysts predict that Physiomics Plc will post -0.13 EPS for the current fiscal year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.